Drug Information for VALPROIC ACID SYRUP (Valproic Acid Oral Solution, USP) 250 mg/5 mL (Morton Grove Pharmaceuticals, Inc.): INDICATIONS AND USAGE

Ads
  • Valproic Acid Syrup (Valproic Acid Oral Solution, USP) is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Valproic Acid Syrup (Valproic Acid Oral Solution, USP) is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures.

    Simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. Complex absence is the term used when other signs are also present.

    SEE WARNINGS FOR STATEMENT REGARDING FATAL HEPATIC DYSFUNCTION.

  • Drug Information Provided by National Library of Medicine (NLM).
Ads